Lyrinex CR 82.5 mg (Tablet (Extended Release))
Unit Price: ৳ 18.00 (3 x 10: ৳ 540.00)
Strip Price: ৳ 180.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Nipro jmi pharma ltd |
| Also available as |
Title and Categories
- Lyrinex CR 82.5 mg Tablet
- Medicine
- Pharmaceuticals
- Neurology
Dimensions
- N/A
Color Options
- N/A
Functions
- Relief of neuropathic pain
- Treatment of partial-onset seizures
- Management of fibromyalgia
Materials
- Pregabalin
Technical Specifications
- Molecular Formula: C8H17NO2
Design Elements
- Extended-release tablet
Usability Features
- Oral route of administration
- Swallow whole, do not split, crush, or chew
- Administration after an evening meal
- Gradual tapering when discontinuing
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy
- Postherpetic neuralgia
- Partial-onset seizures
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Mode of Action
- Binds with high affinity to the alpha2-delta site
Dosage
- Recommended starting doses for different indications
- Maximum recommended dose
- Conversion from Pregabalin capsules to Pregabalin CR capsule tablet
- Recommended dosages for Pregabalin tablet and CR capsule
Administration
- Can be taken with or without food
- Specific instructions for missed doses
- Gradual tapering when discontinuing
Interaction
- Unlikely involvement in significant pharmacokinetic drug interactions
Contraindications
- Known hypersensitivity to Pregabalin or its components
Side Effects
- Common side effects in adults
- Common side effects in pediatric patients
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended
Precautions & Warnings
- Possible occurrence of angioedema
- Increased risk of suicidal thoughts or behavior
- Possible respiratory depression
- Possible impairment of driving or operating machinery
- Need for caution when coadministering with certain medications
Use in Special Populations
- Safety and effectiveness not established in pediatric and adolescent patients
- Safety and effectiveness not established for patients below 1 month of age
Overdose Effects
- Signs and symptoms of overdose
- No specific antidote
- General supportive care
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
Compound Summary
- Molecular Formula: C8H17NO2
- Chemical Structure Image
Commonly Asked Questions
- Description of Lyrinex CR 82.5 mg XR Tablet
- Frequency of use
- Instructions for storage and disposal
- Variation of effects based on disease
- Duration of use
- Continued use even if feeling fine
- Possible coadministration with other medicines
- Potential weight gain as a side effect
- Quick tips for usage